Minerva Neurosciences NERV
NASDAQ NERV
$3.23 -0.12 (-3.58%)
At close: Oct 1, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Short-Term Debt repayments (2014 - 2015)

Updated

Minerva Neurosciences (NERV) recorded Short-Term Debt repayments of $195,656 in FY2015, down 89.6% from $1.88 million in FY2014.

Analysis

Minerva Neurosciences (NERV) Short-Term Debt repayments (2014 - 2015) Analysis & Trends

  • Per Business Quant data, NERV's Short-Term Debt repayments was $1.88 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.45 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Minerva Neurosciences 158.21 Mn 158.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 195,656.00
Sep 30, 2014 1.38 Mn
API Access

Minerva Neurosciences Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=NERV&period=max&api_key=YOUR_API_KEY